ALERT:

Cancer Clinical Trial 20203196

[LCID Study Number: 20203196]

S1904: Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices on Incorporating Chemoprevention Into Care (MiChoice)

The purpose of this study is to investigate the implementation of decision support tools integrated into the electronic health record and patient portal for patients with atypical hyperplasia or lobular carcinoma in situ and healthcare providers.

Disease/Condition: Cancer

Department: Hematology and Oncology

Location(s): Beverly Hospital; Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody; Winchester Hospital

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421

Protocol #: 20203196
Principal Investigator(s): Corrine Zarwan
Study Coordinator(s): Carol Bovest
Trial Phase: Sponsor Initiated Study Observational